HPi4 Products

Description

Stem cells offer a therapeutic promise for many diseases. In the case of diabetes, stem cells offer the promise that beta cells may be generated ex vivo for the possible transplantation and cure of Type I diabetes (Couri CE, et al.). For this to happen, stem cells will need to be isolated and expanded, they will need to be differentiated toward the beta cell lineage, and the differentiated cell progeny used for transplantation may need to be isolated from complex cell mixtures following differentiation. Appropriate markers targeting cell surface molecules on developing and mature pancreatic cells will be required for such research.

Bioinformatics

Alternate Names

human pancreatic endocrine islet cell human pancreatic endocrine islet cell human pancreatic endocrine islet cell human pancreatic endocrine islet cell

Research Areas for HPi4

Find related products by research area and learn more about each of the different research areas below.

Pancreatic Stem Cell Markers
Stem Cell Markers